Bookmark and Share

Compound Summary for: CID 6450551

axitinib

Also known as: 319460-85-0, AG-013736, Inlyta, AG 013736, UNII-C9LVQ0YUXG, AG013736, S1005_Selleck, AG-013736, Axitinib, AG-13736
Molecular Formula: C22H18N4OS   Molecular Weight: 386.46952   InChIKey: RITAVMQDGBJQJZ-FMIVXFBMSA-N
Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3. Axitinib is marketed under the name Inlyta, and if one previous systemic therapy for kidney cell cancer has failed, axitinib is indicated.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _